Spot Trading’s AstraZeneca AZN Stock Holding History

Spot Trading’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$3.13M	Buy	+46,125	New	+$2.91M	0.05%	492
2017 Q2	–	Sell	-7,744	Closed	-$506K	–	3161
2017 Q1	$482K	Buy	7,744 +2,644	+52%	+$154K	0.02%	1266
2016 Q4	$279K	Sell	5,100 -9,450	-65%	-$537K	0.01%	1739
2016 Q3	$956K	Buy	14,550 +12,435	+588%	+$813K	0.02%	1097
2016 Q2	$128K	Sell	2,115 -2,198	-51%	-$128K	﹤0.01%	2449
2016 Q1	$243K	Sell	4,313 -4,114	-49%	-$247K	﹤0.01%	2082
2015 Q4	$572K	Buy	8,427 +2,253	+36%	+$148K	0.01%	1824
2015 Q3	$393K	Buy	+6,174	New	+$406K	﹤0.01%	2221
2014 Q4	–	Sell	-5,410	Closed	-$387K	–	4006
2014 Q3	$386K	Sell	5,410 -160,760	-97%	-$11.8M	﹤0.01%	2738
2014 Q2	$12.3M	Buy	166,170 +117,365	+240%	+$8.48M	0.06%	444
2014 Q1	$3.17M	Buy	48,805 +36,366	+292%	+$2.35M	0.02%	1146
2013 Q4	$739K	Buy	+12,439	New	+$676K	﹤0.01%	2189
2013 Q3	–	Sell	-2,763	Closed	-$139K	–	4093
2013 Q2	$131K	Buy	+2,763	New	+$141K	﹤0.01%	3319

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Spot Trading's AZN Position: Q3 2017 in Review

Spot Trading opened a new position in AstraZeneca (AZN) in Q3 2017: 46,125 shares worth $3.13M. The stake represents 0.05% of the portfolio and ranks #492 among its holdings. This is a return to the name: Spot Trading previously reported a position in AZN as recently as Q1 2017.

Spot Trading first reported a position in AZN in Q2 2013 and has held it in 13 quarters since. The position peaked at $12.3M in Q2 2014. 455 funds tracked by Wall St. Rank hold AZN as of Q3 2017.

Spot Trading held 46,125 shares of AstraZeneca worth $3.13M as of Q3 2017.
AstraZeneca was a new Spot Trading position in Q3 2017.
AstraZeneca made up 0.05% of Spot Trading's portfolio in Q3 2017, its #492 holding.
Spot Trading first reported a position in AstraZeneca in Q2 2013 and has held it in 13 quarters since.
Spot Trading's AstraZeneca position peaked at $12.3M in Q2 2014.
455 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.